Johnson & Johnson (JNJ) Revenue (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Revenue data on file, last reported at $24.1 billion in Q1 2026.

• Quarterly Revenue rose 9.91% year-over-year to $24.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.4 billion (up 7.87% YoY) and the FY2025 annual result came in at $94.2 billion, up 6.05% from the prior year.
• Revenue retreated to $24.1 billion in Q1 2026 per JNJ's latest filing, from $24.6 billion in the prior quarter.
• The five-year high for Revenue was $24.6 billion in Q4 2025, with the low at $19.8 billion in Q2 2022.
• Average Revenue over 5 years is $21.9 billion, with a median of $21.5 billion recorded in 2023.
• Year-over-year, Revenue retreated 14.32% in 2022 and increased 9.91% in 2026.
• Johnson & Johnson's Revenue stood at $20.0 billion in 2022, then grew by 7.0% to $21.4 billion in 2023, then gained by 5.26% to $22.5 billion in 2024, then gained by 9.08% to $24.6 billion in 2025, then declined by 2.04% to $24.1 billion in 2026.
• Business Quant data shows JNJ's Revenue at $24.1 billion in Q1 2026, $24.6 billion in Q4 2025, and $24.0 billion in Q3 2025.